Events2Join

3 Policies to support innovation and access to medicines


Integrating Human Rights into Intellectual Property Policies

Access to medicines (A2M), and particularly to essential medicines, has been recognized as a core component of the right to the highest attainable standard ...

Strategic Goal 1: Objective 1.2 - HHS.gov

HHS supports strategies to reduce costs, improve quality of healthcare services, and ensure access to safe medical devices and drugs for everyone.

Access to medicines through health systems in low - Oxford Academic

These studies answer key questions such as: Can performance-based financing improve availability of essential medicines? How affordable are ...

Enterprise Innovation | Weill Cornell Medicine

We offer unique opportunities for faculty and trainees to transform their research into medical advances through collaborations including access to the Sanders ...

Innovative Medicines Fund - NHS England

The Innovative Medicines Fund will provide a consistent and transparent managed access process for companies offering promising non-cancer medicines at a ...

Intellectual Property - EFPIA

Intellectual property is the key driver of medical innovation. It has enabled unprecedented collaborations between biopharmaceutical innovators and governments, ...

UpToDate: Trusted, evidence-based solutions for modern healthcare

... drug decision support solutions, trusted by over 3 million health professionals worldwide. ... innovation and the application of AI in clinical decision support ...

Patents, Protections and Pandemic: A Trade and Access to ...

Such actions were, in part, supported by trade and investment rules that foster market concentration in innovative sectors such as medicine, ...

Early Access Programs - Biogen

Our Early Access Guiding Principles · Access for appropriate patient(s) to address high unmet medical need in a safe, ethical, and just manner in compliance with ...

National Medicines Policy

... policy environment to drive world-class innovation and ... up-to-date, flexible and supporting timely, safe access to innovative, evidence-based medicines.

Access to Medicines - ohchr

She advocated evidence-based guidelines and policies to promote access to medicines for sexual and reproductive health. 22. Tarek Meguid, Associate ...

Role of innovation in pharmaceutical regulation: A proposal for ...

... support innovation while ensuring only safe, efficacious and quality medicines are authorized. ... innovation ecosystem that supports continuous improvement [3].

Innovation Policy Effectiveness in Emerging Countries

Innovation policies include direct funding support to businesses research and development (R&D) and innovation through grants, subsidies ( ...

Our Strategy 2023-2025 - MPP - Medicines Patent Pool

We will expand access to innovative health technologies, improve the availability and affordability of health products, facilitate the development of ...

Our innovative finance products - MedAccess

Through this approach we are building a diverse portfolio of agreements, supporting access to medicines, diagnostics, vaccines, and other technologies across a ...

Policy as a strategy to innovate in health care? A content analysis of ...

3 CONCEPTUAL BACKGROUND. 3.1 Innovation. In this study, we analyse health policies to identify process-centric and structural innovations in ...

Medicines and Healthcare products Regulatory Agency - GOV.UK

Responses will help shape reforms that will boost UK patients' access to safe and innovative medical products. The importance of giving patients a voice in ...

Towards Open Science: Promoting Innovation in Pharmaceutical ...

(iii) Public Manufacturing of Essential Medicines ... necessary to promote innovation in pharmaceutical R&D in Canada. He explained that innovation in the ...

Advancing digital health: FDA innovation during COVID-19 - Nature

The US Food and Drug Administration (FDA) has issued a number of temporary policies to support digital health innovation during the pandemic.

Increase Access To Medicines | Impact | Eli Lilly and Company

POLICIES & REPORTS. Public Policy. Annual Report & Proxy Statement ... Strengthening and creating new programs that help improve access to Lilly medicines ...